Apostolopoulos Vasso, Lazoura Eliada
The Austin Research Institute, Immunology and Vaccine Laboratory, Studley Road, Heidelberg, VIC 3084, Australia.
Expert Rev Vaccines. 2004 Apr;3(2):151-62. doi: 10.1586/14760584.3.2.151.
The major histocompatibility complex (MHC) presents canonical medium-high-affinity peptides on the surface of antigen-presenting cells to T-cells. Recognition of peptide MHC by T-cells initiates a cascade of signals which maintains a T-cell-dependent immune response. In the design of vaccines, there is need for an understanding of how peptides bind to MHC class I molecules. Herein, the presentation of canonical anchor motif peptides to MHC class I, noncanonical anchor motif peptides, low-affinity peptides, peptides making use of new pockets, short peptides, long peptides, glycopeptides, retro-inverso peptides and prediction programs for peptides binding to MHC class I molecules is discussed. All this information will aid in the design of new and improved peptide-based vaccines.
主要组织相容性复合体(MHC)在抗原呈递细胞表面向T细胞呈递典型的中高亲和力肽段。T细胞对肽-MHC的识别引发一系列信号,维持T细胞依赖性免疫反应。在疫苗设计中,需要了解肽段如何与MHC I类分子结合。本文讨论了向MHC I类呈递典型锚定基序肽段、非典型锚定基序肽段、低亲和力肽段、利用新口袋的肽段、短肽段、长肽段、糖肽段、逆序肽段以及用于预测肽段与MHC I类分子结合的程序。所有这些信息将有助于设计新型和改进型基于肽段的疫苗。